Proceedings of the discussion: 'Tolerability and safety of Sandostatin'.
Popovic
V
V
Department of Endocrinology, St Bartholomew's Hospital, West Smithfield, London, UK.
Chayvialle
J A
JA
Wass
J A
JA
D000172:Acromegaly / Q000188:drug therapy; D002769:Cholelithiasis / Q000139:chemically induced; D004040:Dietary Carbohydrates / Q000378:metabolism; D004361:Drug Tolerance; D016473:Gallbladder Emptying / Q000187:drug effects; D005756:Gastritis / Q000139:chemically induced; D006801:Humans; D015282:Octreotide / Q000009:adverse effects* / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000188:drug therapy; D019966:Substance-Related Disorders
D004040:Dietary Carbohydrates; D015282:Octreotide